4//SEC Filing
Protagenic Therapeutics, Inc.\new 4
Accession 0001437749-16-037066
$PTIXCIK 0001022899operating
Filed
Aug 9, 8:00 PM ET
Accepted
Aug 10, 7:49 PM ET
Size
11.2 KB
Accession
0001437749-16-037066
Insider Transaction Report
Form 4
Barrage Khalil
Director
Transactions
- Award
NSO Stock Option
2016-08-08$1.25/sh+150,000$187,500→ 245,000 total
Footnotes (2)
- [F1]Price indicated refers to exercise price per share of the option grant
- [F2]A previous Form 4 regarding a transaction on June 17, 2016 erroneously indicated that Mr. Barrage beneficially owned 245,000 shares worth of equity securities following the reported transactions on that day. The correct figure would have been 95,000 shares worth of equity securities. 245,000 shares is the correct figure following the current 150,000 option grant.
Documents
Issuer
Protagenic Therapeutics, Inc.\new
CIK 0001022899
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001022899
Filing Metadata
- Form type
- 4
- Filed
- Aug 9, 8:00 PM ET
- Accepted
- Aug 10, 7:49 PM ET
- Size
- 11.2 KB